An experimental coronavirus vaccine entering into human trials in the US could be available in "many millions" of doses by the end of 2020, the CEO of BioNTech sayshttps://t.co/GB1B4ZB7Hu pic.twitter.com/aItMv0YKmp

— CNN Breaking News (@cnnbrk) May 5, 2020